215 related articles for article (PubMed ID: 24086677)
1. Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration.
Honea RA; Cruchaga C; Perea RD; Saykin AJ; Burns JM; Weinberger DR; Goate AM;
PLoS One; 2013; 8(9):e76001. PubMed ID: 24086677
[TBL] [Abstract][Full Text] [Related]
2. BDNF genotype is associated with hippocampal volume in mild traumatic brain injury.
Hayes JP; Reagan A; Logue MW; Hayes SM; Sadeh N; Miller DR; Verfaellie M; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
Genes Brain Behav; 2018 Feb; 17(2):107-117. PubMed ID: 28755387
[TBL] [Abstract][Full Text] [Related]
3.
Fischer DL; Auinger P; Goudreau JL; Paumier KL; Cole-Strauss A; Kemp CJ; Lipton JW; Sortwell CE
Front Neurol; 2022; 13():1053591. PubMed ID: 36468063
[TBL] [Abstract][Full Text] [Related]
4. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
[TBL] [Abstract][Full Text] [Related]
6. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
7. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease.
Bodner SM; Berrettini W; van Deerlin V; Bennett DA; Wilson RS; Trojanowski JQ; Arnold SE
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):1-5. PubMed ID: 15635706
[TBL] [Abstract][Full Text] [Related]
10. NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy.
Warburton A; Miyajima F; Shazadi K; Crossley J; Johnson MR; Marson AG; Baker GA; Quinn JP; Sills GJ
Epilepsy Behav; 2016 Jan; 54():117-27. PubMed ID: 26708060
[TBL] [Abstract][Full Text] [Related]
11. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
[TBL] [Abstract][Full Text] [Related]
12. The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer's Disease Risk.
Belbin O; Morgan K; Medway C; Warden D; Cortina-Borja M; van Duijn CM; Adams HHH; Frank-Garcia A; Brookes K; Sánchez-Juan P; Alvarez V; Heun R; Kölsch H; Coto E; Kehoe PG; Rodriguez-Rodriguez E; Bullido MJ; Ikram MA; Smith AD; Lehmann DJ
J Alzheimers Dis; 2019; 68(4):1535-1547. PubMed ID: 30909233
[TBL] [Abstract][Full Text] [Related]
13. BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
Fischer DL; Auinger P; Goudreau JL; Cole-Strauss A; Kieburtz K; Elm JJ; Hacker ML; Charles PD; Lipton JW; Pickut BA; Sortwell CE
Neurotherapeutics; 2020 Oct; 17(4):1785-1795. PubMed ID: 33215284
[TBL] [Abstract][Full Text] [Related]
14. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
[TBL] [Abstract][Full Text] [Related]
15. BDNF VAL66MET polymorphism and memory decline across the spectrum of Alzheimer's disease.
Lim YY; Laws SM; Perin S; Pietrzak RH; Fowler C; Masters CL; Maruff P;
Genes Brain Behav; 2021 Jun; 20(5):e12724. PubMed ID: 33369083
[TBL] [Abstract][Full Text] [Related]
16. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study.
Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington K; Bourgeat P; Bush AI; Martins RN; Masters CL; Rowe CC; Maruff P;
PLoS One; 2014; 9(1):e86498. PubMed ID: 24475133
[TBL] [Abstract][Full Text] [Related]
17. The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.
Chuu JY; Taylor JL; Tinklenberg J; Noda A; Yesavage J; Murphy GM
J Alzheimers Dis; 2006 Mar; 9(1):43-9. PubMed ID: 16627933
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease.
Huang R; Huang J; Cathcart H; Smith S; Poduslo SE
J Med Genet; 2007 Feb; 44(2):e66. PubMed ID: 17293537
[TBL] [Abstract][Full Text] [Related]
19. The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
Bessi V; Mazzeo S; Bagnoli S; Padiglioni S; Carraro M; Piaceri I; Bracco L; Sorbi S; Nacmias B
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):471-482. PubMed ID: 31560105
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the Resilience Effect of Neurodegeneration for the Mechanistic Pathway of Alzheimer's Disease.
Hu D; Liu C; Xia K; Abramowitz A; Wu G;
J Alzheimers Dis; 2021; 84(3):1351-1362. PubMed ID: 34657890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
